$XERS XERIS PHARMACEUTICALS INC Insider Trading Week 25/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in XERIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in XERIS PHARMACEUTICALS INC in week 25/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | JOHNSON KENNETH ERLAND | See Remarks | Option Exercise | C | 0.00 | 4,000 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | JOHNSON KENNETH ERLAND | See Remarks | Buy | C | 0.00 | 2,245 | 0 | 2,245 | 0 to 2.2 K |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | C | 0.00 | 23,922 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | C | 0.00 | 23,922 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | C | 0.00 | 13,430 | 0 | 13,430 | 0 to 13.4 K |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | C | 0.00 | 13,430 | 0 | 13,430 | 0 to 13.4 K |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Deutsch Barry M. | Chief Financial Off ... | Option Exercise | C | 0.00 | 3,987 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Deutsch Barry M. | Chief Financial Off ... | Option Exercise | C | 0.00 | 3,987 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Deutsch Barry M. | Chief Financial Off ... | Buy | C | 0.00 | 2,238 | 0 | 23,292 | 21.1 K to 23.3 K (+10.63 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Deutsch Barry M. | Chief Financial Off ... | Buy | C | 0.00 | 2,238 | 0 | 23,292 | 21.1 K to 23.3 K (+10.63 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Shannon John Patrick Jr | See Remarks | Option Exercise | C | 0.00 | 16,000 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Shannon John Patrick Jr | See Remarks | Option Exercise | C | 0.00 | 16,000 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Shannon John Patrick Jr | See Remarks | Buy | C | 0.00 | 8,983 | 0 | 8,983 | 0 to 9 K |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Shannon John Patrick Jr | See Remarks | Buy | C | 0.00 | 8,983 | 0 | 8,983 | 0 to 9 K |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Option Exercise | C | 0.00 | 12,701 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Option Exercise | C | 0.00 | 12,701 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Option Exercise | C | 0.00 | 53,849 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Option Exercise | C | 0.00 | 53,849 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Buy | C | 0.00 | 7,130 | 0 | 489,323 | 482.2 K to 489.3 K (+1.48 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Buy | C | 0.00 | 7,130 | 0 | 489,323 | 482.2 K to 489.3 K (+1.48 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Buy | C | 0.00 | 30,232 | 0 | 482,193 | 452 K to 482.2 K (+6.69 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Buy | C | 0.00 | 30,232 | 0 | 482,193 | 452 K to 482.2 K (+6.69 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,557,292 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,557,292 | 0 | 0 | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 624,333 | 9,364,995 | 1,498,666 | 874.3 K to 1.5 M (+71.41 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 125,667 | 1,885,005 | 1,000,000 | 874.3 K to 1000 K (+14.37 %) |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 874,333 | 0 | 874,333 | 0 to 874.3 K |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 874,333 | 0 | 874,333 | 0 to 874.3 K |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Redmile Group, LLC | Option Exercise | C | 0.00 | 3,109,796 | 0 | 0 | ||
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Redmile Group, LLC | Buy | P | 15.00 | 666,668 | 10,000,020 | 2,412,642 | 1.7 M to 2.4 M (+38.18 %) | |
| Jun 27 2018 | XERS | XERIS PHARMACEUTIC ... | Redmile Group, LLC | Buy | C | 0.00 | 1,745,974 | 0 | 1,745,974 | 0 to 1.7 M | |
| Jun 25 2018 | XERS | XERIS PHARMACEUTIC ... | Palmetto Partners, Ltd. | 10% Owner | Option Exercise | C | 0.00 | 797,384 | 0 | 0 | |
| Jun 25 2018 | XERS | XERIS PHARMACEUTIC ... | Palmetto Partners, Ltd. | 10% Owner | Option Exercise | C | 0.00 | 1,036,599 | 0 | 0 | |
| Jun 25 2018 | XERS | XERIS PHARMACEUTIC ... | Palmetto Partners, Ltd. | 10% Owner | Option Exercise | C | 0.00 | 1,657,125 | 0 | 0 | |
| Jun 25 2018 | XERS | XERIS PHARMACEUTIC ... | Palmetto Partners, Ltd. | 10% Owner | Buy | P | 15.00 | 150,000 | 2,250,000 | 2,110,061 | 2 M to 2.1 M (+7.65 %) |
| Jun 25 2018 | XERS | XERIS PHARMACEUTIC ... | Palmetto Partners, Ltd. | 10% Owner | Buy | C | 0.00 | 447,686 | 0 | 1,960,061 | 1.5 M to 2 M (+29.60 %) |
| Jun 25 2018 | XERS | XERIS PHARMACEUTIC ... | Palmetto Partners, Ltd. | 10% Owner | Buy | C | 0.00 | 581,992 | 0 | 1,512,375 | 930.4 K to 1.5 M (+62.55 %) |
| Jun 25 2018 | XERS | XERIS PHARMACEUTIC ... | Palmetto Partners, Ltd. | 10% Owner | Buy | C | 0.00 | 930,383 | 0 | 930,383 | 0 to 930.4 K |